Mammalian artificial chromosomes and clinical applications for genetic modification of stem cells: an overview.

Robert L. Katona, Sandra L. Vanderbyl, Carl F. Perez

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Modifying multipotent, self-renewing human stem cells with mammalian artificial chromosomes (MACs), present a promising clinical strategy for numerous diseases, especially ex vivo cell therapies that can benefit from constitutive or overexpression of therapeutic gene(s). MACs are nonintegrating, autonomously replicating, with the capacity to carry large cDNA or genomic sequences, which in turn enable potentially prolonged, safe, and regulated therapeutic transgene expression, and render MACs as attractive genetic vectors for "gene replacement" or for controlling differentiation pathways in progenitor cells. The status quo is that the most versatile target cell would be one that was pluripotent and self-renewing to address multiple disease target cell types, thus making multilineage stem cells, such as adult derived early progenitor cells and embryonic stem cells, as attractive universal host cells. We will describe the progress of MAC technologies, the subsequent modifications of stem cells, and discuss the establishment of MAC platform stem cell lines to facilitate proof-of-principle studies and preclinical development.

Original languageEnglish
Pages (from-to)199-216
Number of pages18
JournalMethods in molecular biology (Clifton, N.J.)
Volume738
DOIs
Publication statusPublished - Aug 3 2011

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Fingerprint Dive into the research topics of 'Mammalian artificial chromosomes and clinical applications for genetic modification of stem cells: an overview.'. Together they form a unique fingerprint.

  • Cite this